METIS TECHBIO-P (07666.HK): Plans A-Share Listing, Hires Tutor

On 18 November 2026, METIS TECHBIO-P (07666.HK) said the board approved starting work on an A-share listing and has engaged a pre-listing tutoring institution.

NewTimeSpace News: On 18 November 2026, Metis TechBio Co., Ltd. (stock code: 7666) announced that, in order to facilitate business development and enhance its overall competitive strength, it intends to commence work relating to the issuance of RMB-denominated ordinary shares (A shares) and the listing of such shares, and the board has resolved and approved the commencement of the relevant work.

According to the announcement, the Company has engaged a pre-listing tutoring institution and will submit a tutoring filing application to the relevant regulatory authorities in accordance with applicable laws and regulations; as at the date of the announcement, the board has not approved any other plans relating to the proposed A-share listing, nor has the Company applied to any PRC regulatory authority for approval.

The Company cautioned that the detailed plans and expected timetable are subject to further approval by the board and the general meeting, as well as the consent of the CSRC and other relevant regulatory authorities, and that the proposed A-share listing may or may not proceed, with no assurance that it will take place or as to timing. The Company will make further filings and announcements in due course.

The announcement also noted that Metis TechBio was co-founded in 2020 by Dr. Hongming Chen, a member of the U.S. National Academy of Engineering, and MIT scientists Dr. Lai Caida and Dr. Wang Wenshou, and listed on the Hong Kong Stock Exchange on 13 May 2026; it has developed the AI-driven NanoForge delivery platform, with a lipid nanoparticle library of over 10 million and four core solutions: AiLNP, AiRNA, AiProtein and AiTEM.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.